Methods of modulating cytokine activity, related reagents

A technology for regulating immunity and drug delivery, which is applied in the field of mammalian cytokines and can solve problems such as stimulation

Inactive Publication Date: 2007-02-28
SCHERING AG
View PDF9 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

According to Trinchieri et al., supra, IL-27 alone does not appear to have a major role in the initial TH1-type response, but, instead, it stimulates early IFNγ production without seriously affecting T cell differentiation to TH1-type

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment I

Example I. General method

[0097]Standard methods in biochemistry and molecular biology have been published (see, e.g., Maniatis et al. (1982) Molecular Cloning, A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY; Sambrook and Russell (2001) Molecular Cloning, 3rd. , Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY; Wu (1993) RecombinantDNA, Vol. 217, Academic Press, San Diego, CA). Standard methods are also described in Ausbel et al. (2001) Current Protocols in Molecular Biology, Vols. 1-4, John Wiley and Sons, Inc. New York, NY, which describes cloning in bacterial cells and DNA mutagenesis (Vol. 1) , Cloning in Mammalian Cells and Yeast (Vol.2), Glycosides and Protein Expression (Vol.3), and Bioinformatics (Vol.4).

[0098] A method for protein purification involving immunoprecipitation, chromatography, electrophoresis, centrifugation and crystallization has been published (Coligan et al. (2000) Current Protocols in Protein Science,...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
affinityaaaaaaaaaa
Login to view more

Abstract

Provided are methods of modulating cytokine activity, e.g., for the purpose of treating immune and inflammatory disorders. Also provided are methods of administering agonists or antagonists of IL-27 and IL-27 receptor.

Description

[0001] This application claims the benefit of U.S. Provisional Patent Application no. 60 / 545,762, filed February 17, 2004, which is hereby incorporated by reference in its entirety. field of invention [0001] The present invention generally relates to the use of mammalian cytokines. More specifically, the present invention discloses receptor subunits of the IL-27 receptor. Background of the invention [0002] The immune system protects individuals against infectious agents such as bacteria, multicellular organisms, and cancer. This system includes several types of lymphoid and myeloid cells, such as monocytes, macrophages, dendritic cells (DCs), eosinophils, T cells, B cells, and neutrophils. These lymphoid and myeloid cells often produce signaling proteins called cytokines. The immune response includes inflammation, the accumulation of immune cells throughout the body or especially locally. In response to infectious or foreign substances, immune cells secrete cytokines,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K45/00A61K38/20A61K38/17A61K39/395A61P9/10A61P11/06A61P17/06A61P19/02A61P37/02A61P37/08A61K48/00C07K16/24C07K16/28
CPCA61K39/395C07K16/2866A61K38/20C07K16/244G01N33/00A61K38/1793C07K2317/73C12N15/00A61P1/04A61P11/00A61P11/06A61P11/08A61P17/02A61P17/06A61P19/02A61P29/00A61P35/00A61P35/04A61P37/00A61P37/02A61P37/08A61P43/00A61P9/10
Inventor R·A·凯斯特林T·K·麦克拉那汉S·普夫兰茨
Owner SCHERING AG
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap